What is nanomedecine ?

Nanomedicine is the application of nanotechnology to achieve innovation in medicine, providing new therapeutics and diagnostic tools. It exploits the properties of materials at the nanometric scale (10^-9 m). The nanometric size is the scale of many biological mechanisms in the human body allowing nanoparticles and nanomaterials used in medicine to cross natural barriers and to access new sites of drug delivery and/or to interact with DNA or small proteins at different levels, in blood or within organs, tissues or cells, improving the therapeutic outcomes and reducing side effects.

In short:

• Nanomedicine aims at reaching improved therapeutic outcome and reduced side-effects;
• 200 billion € business worldwide in 2020, with a foreseen annual growth of 12.6% (estimated 500 billion € in 2028);
• Shift from ‘simple’ chemical drugs to complex nano structures with nano-specific critical quality attributes (CQAs):

Do you want to know more?

To know more about nanomedicine, have a look at the video produced by the ETPN together with the NANOMED2020 consortium

Are you curious to discover more projects on Nanomedicine? Visit the ETPN webpage European Nanomedicine projects